BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36193846)

  • 1. Dysregulation of integrin αvβ3 and α5β1 impedes migration of placental endothelial cells in fetal growth restriction.
    Gumina DL; Ji S; Flockton A; McPeak K; Stich D; Moldovan R; Su EJ
    Development; 2022 Oct; 149(19):dev200717. PubMed ID: 36193846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenic Function of Human Placental Endothelial Cells in Severe Fetal Growth Restriction Is Not Rescued by Individual Extracellular Matrix Proteins.
    Sayres L; Flockton AR; Ji S; Rey Diaz C; Gumina DL; Su EJ
    Cells; 2023 Sep; 12(19):. PubMed ID: 37830553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive Association of Tie1 and Tie2 with Endothelial Integrins is Functionally Modulated by Angiopoietin-1 and Fibronectin.
    Dalton AC; Shlamkovitch T; Papo N; Barton WA
    PLoS One; 2016; 11(10):e0163732. PubMed ID: 27695111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis.
    Danen EH; Sonneveld P; Brakebusch C; Fassler R; Sonnenberg A
    J Cell Biol; 2002 Dec; 159(6):1071-86. PubMed ID: 12486108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial FN (Fibronectin) Deposition by α5β1 Integrins Drives Atherogenic Inflammation.
    Al-Yafeai Z; Yurdagul A; Peretik JM; Alfaidi M; Murphy PA; Orr AW
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2601-2614. PubMed ID: 30354234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the development of severe fetal growth restriction.
    Gumina DL; Su EJ
    Clin Sci (Lond); 2023 Apr; 137(8):679-695. PubMed ID: 37186255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction.
    Lappas M; McCracken S; McKelvey K; Lim R; James J; Roberts CT; Fournier T; Alfaidy N; Powell KL; Borg AJ; Morris JM; Leaw B; Singh H; Ebeling PR; Wallace EM; Parry LJ; Dimitriadis E; Murthi P
    Mol Hum Reprod; 2018 Feb; 24(2):94-109. PubMed ID: 29272530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrate engagement of integrins α5β1 and αvβ3 is necessary, but not sufficient, for high directional persistence in migration on fibronectin.
    Missirlis D; Haraszti T; Scheele Cv; Wiegand T; Diaz C; Neubauer S; Rechenmacher F; Kessler H; Spatz JP
    Sci Rep; 2016 Mar; 6():23258. PubMed ID: 26987342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.
    Ly DP; Corbett SA
    J Surg Res; 2005 Feb; 123(2):200-5. PubMed ID: 15680379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment of α
    Diaz C; Neubauer S; Rechenmacher F; Kessler H; Missirlis D
    J Cell Sci; 2020 Jan; 133(1):. PubMed ID: 31780581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra.
    Li L; Liu F; Welser-Alves JV; McCullough LD; Milner R
    Exp Neurol; 2012 Jan; 233(1):283-91. PubMed ID: 22056225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of disintegrin-metalloproteinases ADAM-15 and ADAM-9 following upregulation of integrins alpha5beta1 and alphavbeta3 in atherosclerosis.
    Al-Fakhri N; Wilhelm J; Hahn M; Heidt M; Hehrlein FW; Endisch AM; Hupp T; Cherian SM; Bobryshev YV; Lord RS; Katz N
    J Cell Biochem; 2003 Jul; 89(4):808-23. PubMed ID: 12858346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accessibility to the fibronectin synergy site in a 3D matrix regulates engagement of alpha5beta1 versus alphavbeta3 integrin receptors.
    Mao Y; Schwarzbauer JE
    Cell Commun Adhes; 2006; 13(5-6):267-77. PubMed ID: 17162669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen.
    Ly DP; Zazzali KM; Corbett SA
    J Biol Chem; 2003 Jun; 278(24):21878-85. PubMed ID: 12676956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integrin expression profile modulates orientation and dynamics of force transmission at cell-matrix adhesions.
    Balcioglu HE; van Hoorn H; Donato DM; Schmidt T; Danen EH
    J Cell Sci; 2015 Apr; 128(7):1316-26. PubMed ID: 25663698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of α5β1 and αVβ3 integrins.
    Huang H; Huang Q; Wang F; Milner R; Li L
    J Neuroinflammation; 2016 Sep; 13(1):227. PubMed ID: 27586239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-β and fetoplacental endothelial prostanoid biosynthesis: a link to clinically demonstrated fetal growth restriction.
    Su EJ; Ernst L; Abdallah N; Chatterton R; Xin H; Monsivais D; Coon J; Bulun SE
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1558-67. PubMed ID: 21832119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction.
    Regnault TR; de Vrijer B; Galan HL; Davidsen ML; Trembler KA; Battaglia FC; Wilkening RB; Anthony RV
    J Physiol; 2003 Jul; 550(Pt 2):641-56. PubMed ID: 12740423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell free hemoglobin in the fetoplacental circulation: a novel cause of fetal growth restriction?
    Brook A; Hoaksey A; Gurung R; Yoong EEC; Sneyd R; Baynes GC; Bischof H; Jones S; Higgins LE; Jones C; Greenwood SL; Jones RL; Gram M; Lang I; Desoye G; Myers J; Schneider H; Hansson SR; Crocker IP; Brownbill P
    FASEB J; 2018 Oct; 32(10):5436-5446. PubMed ID: 29723064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.